ALKERMES | Despesas Operacionais

Operating Expenses Alterar Data
AbbVie USD 11.11B 540M 2023-12
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Malin Corporation EUR 2.2M 800K 2023-06
Merck USD 16.56B 6.35B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Otsuka Holdings JPY 459.58B 14.3B 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



ALKERMES Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.